[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Bioengineered Protein Drugs Market Report 2017

December 2017 | 116 pages | ID: A935A8FF90FEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Bioengineered Protein Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Bioengineered Protein Drugs for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Bioengineered Protein Drugs market competition by top manufacturers/players, with Bioengineered Protein Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Amgen, Inc.
  • Bayer AG
  • Merck & Co., Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Biocon Ltd.
  • Eli Lilly and Company
  • Sanofi
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • JanssenNovartis AG
  • Panacea Biotec
  • ProBioGen AG
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Therapeutic Proteins
  • Monoclonal Antibodies
  • Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Diabetes and Hormonal Disorders
  • Genetic and Fertility Disorders
  • Cancers
  • Organ Transplants
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Bioengineered Protein Drugs Market Report 2017

1 BIOENGINEERED PROTEIN DRUGS OVERVIEW

1.1 Product Overview and Scope of Bioengineered Protein Drugs
1.2 Classification of Bioengineered Protein Drugs by Product Category
  1.2.1 Asia-Pacific Bioengineered Protein Drugs Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Bioengineered Protein Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Therapeutic Proteins
  1.2.4 Monoclonal Antibodies
  1.2.5 Vaccines
1.3 Asia-Pacific Bioengineered Protein Drugs Market by Application/End Users
  1.3.1 Asia-Pacific Bioengineered Protein Drugs Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Diabetes and Hormonal Disorders
  1.3.3 Genetic and Fertility Disorders
  1.3.4 Cancers
  1.3.5 Organ Transplants
  1.3.6 Others
1.4 Asia-Pacific Bioengineered Protein Drugs Market by Region
  1.4.1 Asia-Pacific Bioengineered Protein Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Bioengineered Protein Drugs (2012-2022)
  1.5.1 Asia-Pacific Bioengineered Protein Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC BIOENGINEERED PROTEIN DRUGS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Bioengineered Protein Drugs Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Bioengineered Protein Drugs Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Bioengineered Protein Drugs (Volume and Value) by Type
  2.2.1 Asia-Pacific Bioengineered Protein Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Bioengineered Protein Drugs (Volume) by Application
2.4 Asia-Pacific Bioengineered Protein Drugs (Volume and Value) by Region
  2.4.1 Asia-Pacific Bioengineered Protein Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Market Share by Region (2012-2017)

3 CHINA BIOENGINEERED PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 China Bioengineered Protein Drugs Sales and Value (2012-2017)
  3.1.1 China Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 China Bioengineered Protein Drugs Sales Price Trend (2012-2017)
3.2 China Bioengineered Protein Drugs Sales Volume and Market Share by Type
3.3 China Bioengineered Protein Drugs Sales Volume and Market Share by Application

4 JAPAN BIOENGINEERED PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Bioengineered Protein Drugs Sales and Value (2012-2017)
  4.1.1 Japan Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Bioengineered Protein Drugs Sales Price Trend (2012-2017)
4.2 Japan Bioengineered Protein Drugs Sales Volume and Market Share by Type
4.3 Japan Bioengineered Protein Drugs Sales Volume and Market Share by Application

5 SOUTH KOREA BIOENGINEERED PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Bioengineered Protein Drugs Sales and Value (2012-2017)
  5.1.1 South Korea Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Bioengineered Protein Drugs Sales Price Trend (2012-2017)
5.2 South Korea Bioengineered Protein Drugs Sales Volume and Market Share by Type
5.3 South Korea Bioengineered Protein Drugs Sales Volume and Market Share by Application

6 TAIWAN BIOENGINEERED PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Bioengineered Protein Drugs Sales and Value (2012-2017)
  6.1.1 Taiwan Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Bioengineered Protein Drugs Sales Price Trend (2012-2017)
6.2 Taiwan Bioengineered Protein Drugs Sales Volume and Market Share by Type
6.3 Taiwan Bioengineered Protein Drugs Sales Volume and Market Share by Application

7 INDIA BIOENGINEERED PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 India Bioengineered Protein Drugs Sales and Value (2012-2017)
  7.1.1 India Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 India Bioengineered Protein Drugs Sales Price Trend (2012-2017)
7.2 India Bioengineered Protein Drugs Sales Volume and Market Share by Type
7.3 India Bioengineered Protein Drugs Sales Volume and Market Share by Application

8 SOUTHEAST ASIA BIOENGINEERED PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Bioengineered Protein Drugs Sales and Value (2012-2017)
  8.1.1 Southeast Asia Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Bioengineered Protein Drugs Sales Price Trend (2012-2017)
8.2 Southeast Asia Bioengineered Protein Drugs Sales Volume and Market Share by Type
8.3 Southeast Asia Bioengineered Protein Drugs Sales Volume and Market Share by Application

9 AUSTRALIA BIOENGINEERED PROTEIN DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Bioengineered Protein Drugs Sales and Value (2012-2017)
  9.1.1 Australia Bioengineered Protein Drugs Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Bioengineered Protein Drugs Sales Price Trend (2012-2017)
9.2 Australia Bioengineered Protein Drugs Sales Volume and Market Share by Type
9.3 Australia Bioengineered Protein Drugs Sales Volume and Market Share by Application

10 ASIA-PACIFIC BIOENGINEERED PROTEIN DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Abbott Laboratories
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 F. Hoffmann-La Roche Ltd
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Amgen, Inc.
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Bayer AG
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Bayer AG Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Merck & Co., Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Dr. Reddy’s Laboratories Ltd.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Dr. Reddy’s Laboratories Ltd. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Biocon Ltd.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Eli Lilly and Company
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Sanofi
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Sanofi Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 GlaxoSmithKline plc
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Bioengineered Protein Drugs Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Johnson & Johnson
10.12 JanssenNovartis AG
10.13 Panacea Biotec
10.14 ProBioGen AG

11 BIOENGINEERED PROTEIN DRUGS MANUFACTURING COST ANALYSIS

11.1 Bioengineered Protein Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Bioengineered Protein Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Bioengineered Protein Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC BIOENGINEERED PROTEIN DRUGS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Bioengineered Protein Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Bioengineered Protein Drugs Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Bioengineered Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Bioengineered Protein Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Bioengineered Protein Drugs Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Bioengineered Protein Drugs Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Bioengineered Protein Drugs Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Bioengineered Protein Drugs Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Bioengineered Protein Drugs
Figure Asia-Pacific Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Therapeutic Proteins Product Picture
Figure Monoclonal Antibodies Product Picture
Figure Vaccines Product Picture
Figure Asia-Pacific Bioengineered Protein Drugs Sales (MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Bioengineered Protein Drugs by Application in 2016
Figure Diabetes and Hormonal Disorders Examples
Table Key Downstream Customer in Diabetes and Hormonal Disorders
Figure Genetic and Fertility Disorders Examples
Table Key Downstream Customer in Genetic and Fertility Disorders
Figure Cancers Examples
Table Key Downstream Customer in Cancers
Figure Organ Transplants Examples
Table Key Downstream Customer in Organ Transplants
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Bioengineered Protein Drugs Market Size (Million USD) by Region (2012-2022)
Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Volume (MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Market Major Players Product Sales Volume (MT)(2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales (MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Bioengineered Protein Drugs Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Bioengineered Protein Drugs Sales Share by Players/Suppliers
Figure Asia-Pacific Bioengineered Protein Drugs Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Bioengineered Protein Drugs Revenue Share by Players
Figure 2017 Asia-Pacific Bioengineered Protein Drugs Revenue Share by Players
Table Asia-Pacific Bioengineered Protein Drugs Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Bioengineered Protein Drugs by Type (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bioengineered Protein Drugs by Type (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Volume (MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Bioengineered Protein Drugs by Region (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Region in 2016
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Bioengineered Protein Drugs by Region (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share by Region in 2016
Table Asia-Pacific Bioengineered Protein Drugs Sales Volume (MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Bioengineered Protein Drugs Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share by Application (2012-2017)
Figure China Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Bioengineered Protein Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table China Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2017)
Table China Bioengineered Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Bioengineered Protein Drugs Sales Volume Market Share by Type in 2016
Table China Bioengineered Protein Drugs Sales Volume (MT) by Applications (2012-2017)
Table China Bioengineered Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Bioengineered Protein Drugs Sales Volume Market Share by Application in 2016
Figure Japan Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Bioengineered Protein Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2017)
Table Japan Bioengineered Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Bioengineered Protein Drugs Sales Volume Market Share by Type in 2016
Table Japan Bioengineered Protein Drugs Sales Volume (MT) by Applications (2012-2017)
Table Japan Bioengineered Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Bioengineered Protein Drugs Sales Volume Market Share by Application in 2016
Figure South Korea Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Bioengineered Protein Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table South Korea Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2017)
Table South Korea Bioengineered Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure South Korea Bioengineered Protein Drugs Sales Volume Market Share by Type in 2016
Table South Korea Bioengineered Protein Drugs Sales Volume (MT) by Applications (2012-2017)
Table South Korea Bioengineered Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure South Korea Bioengineered Protein Drugs Sales Volume Market Share by Application in 2016
Figure Taiwan Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Bioengineered Protein Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Taiwan Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2017)
Table Taiwan Bioengineered Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Bioengineered Protein Drugs Sales Volume Market Share by Type in 2016
Table Taiwan Bioengineered Protein Drugs Sales Volume (MT) by Applications (2012-2017)
Table Taiwan Bioengineered Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Bioengineered Protein Drugs Sales Volume Market Share by Application in 2016
Figure India Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Bioengineered Protein Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table India Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2017)
Table India Bioengineered Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Bioengineered Protein Drugs Sales Volume Market Share by Type in 2016
Table India Bioengineered Protein Drugs Sales Volume (MT) by Application (2012-2017)
Table India Bioengineered Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Bioengineered Protein Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Bioengineered Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Bioengineered Protein Drugs Sales Volume (MT) by Applications (2012-2017)
Table Southeast Asia Bioengineered Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Bioengineered Protein Drugs Sales Volume Market Share by Application in 2016
Figure Australia Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Bioengineered Protein Drugs Sales Price (USD/Kg) Trend (2012-2017)
Table Australia Bioengineered Protein Drugs Sales Volume (MT) by Type (2012-2017)
Table Australia Bioengineered Protein Drugs Sales Volume Market Share by Type (2012-2017)
Figure Australia Bioengineered Protein Drugs Sales Volume Market Share by Type in 2016
Table Australia Bioengineered Protein Drugs Sales Volume (MT) by Applications (2012-2017)
Table Australia Bioengineered Protein Drugs Sales Volume Market Share by Application (2012-2017)
Figure Australia Bioengineered Protein Drugs Sales Volume Market Share by Application in 2016
Table Abbott Laboratories Bioengineered Protein Drugs Basic Information List
Table Abbott Laboratories Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Basic Information List
Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen, Inc. Bioengineered Protein Drugs Basic Information List
Table Amgen, Inc. Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen, Inc. Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Amgen, Inc. Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Amgen, Inc. Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer AG Bioengineered Protein Drugs Basic Information List
Table Bayer AG Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer AG Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Bayer AG Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer AG Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck & Co., Inc. Bioengineered Protein Drugs Basic Information List
Table Merck & Co., Inc. Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck & Co., Inc. Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Dr. Reddy’s Laboratories Ltd. Bioengineered Protein Drugs Basic Information List
Table Dr. Reddy’s Laboratories Ltd. Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Dr. Reddy’s Laboratories Ltd. Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Dr. Reddy’s Laboratories Ltd. Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Dr. Reddy’s Laboratories Ltd. Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Biocon Ltd. Bioengineered Protein Drugs Basic Information List
Table Biocon Ltd. Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biocon Ltd. Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Biocon Ltd. Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Biocon Ltd. Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly and Company Bioengineered Protein Drugs Basic Information List
Table Eli Lilly and Company Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly and Company Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Sanofi Bioengineered Protein Drugs Basic Information List
Table Sanofi Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure Sanofi Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline plc Bioengineered Protein Drugs Basic Information List
Table GlaxoSmithKline plc Bioengineered Protein Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Bioengineered Protein Drugs Sales (MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Bioengineered Protein Drugs Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline plc Bioengineered Protein Drugs Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Bioengineered Protein Drugs Basic Information List
Table JanssenNovartis AG Bioengineered Protein Drugs Basic Information List
Table Panacea Biotec Bioengineered Protein Drugs Basic Information List
Table ProBioGen AG Bioengineered Protein Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Kg) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bioengineered Protein Drugs
Figure Manufacturing Process Analysis of Bioengineered Protein Drugs
Figure Bioengineered Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2016
Table Major Buyers of Bioengineered Protein Drugs
Table Distributors/Traders List
Figure Asia-Pacific Bioengineered Protein Drugs Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Price (USD/Kg) and Trend Forecast (2017-2022)
Table Asia-Pacific Bioengineered Protein Drugs Sales Volume (MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Region in 2022
Figure China Bioengineered Protein Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Bioengineered Protein Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Bioengineered Protein Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Bioengineered Protein Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Bioengineered Protein Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Bioengineered Protein Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Bioengineered Protein Drugs Sales (MT) and Growth Rate Forecast (2017-2022)
Figure Australia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Bioengineered Protein Drugs Sales (MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Bioengineered Protein Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Bioengineered Protein Drugs Price (USD/Kg) Forecast by Type (2017-2022)
Table Asia-Pacific Bioengineered Protein Drugs Sales (MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Bioengineered Protein Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories